Product image of Metilprednizolon Teva (Methylprednisolone Sodium Succinate) supplied by GNH India

Metilprednizolon Teva

Active Ingredient:
Methylprednisolone Sodium Succinate
Origin:
EU

Metilprednizolon Teva (Methylprednisolone Sodium Succinate)

Methylprednisolone Sodium Succinate, the active ingredient in Metilprednizolon Teva, is a glucocorticoid presented as an injectable solution for intravenous use. It is employed to treat acute exacerbations of asthma and chronic obstructive pulmonary disease, severe allergic reactions, rheumatic and musculoskeletal disorders, autoimmune diseases, adrenal insufficiency, and to prevent postoperative inflammation.

GNH India supplies Metilprednizolon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Teva Gyógyszergyár Zrt

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metilprednizolon Teva, a systemic glucocorticoid, is indicated for several inflammatory and immune‑mediated conditions.

  • Acute asthma and COPD exacerbations: rapidly reduces airway inflammation and improves airflow.
  • Severe allergic reactions (e.g., anaphylaxis): suppresses mast‑cell mediator release and stabilises the immune response.
  • Rheumatic and musculoskeletal disorders: diminishes joint inflammation and pain.
  • Autoimmune diseases: modulates immune activity to control disease flares.
  • Postoperative inflammation prevention: limits surgical tissue swelling and pain.

How It Works

  • Methylprednisolone Sodium Succinate enters cells and binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus. This complex interacts with glucocorticoid response elements on DNA, altering transcription of multiple genes. The result is decreased production of pro‑inflammatory cytokines, inhibition of leukocyte migration, and suppression of immune cell activation, producing potent anti‑inflammatory and immunosuppressive effects.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Increased blood glucose levels.
  • Fluid retention and peripheral edema.
  • Elevated blood pressure.
  • Mood changes such as anxiety or insomnia.
  • Increased appetite and weight gain.
  • Gastro‑intestinal discomfort.

Serious or Rare Side Effects

  • Severe infections due to immunosuppression.
  • Adrenal insufficiency on abrupt discontinuation.
  • Gastro‑intestinal bleeding or ulceration.
  • Anaphylactic or severe hypersensitivity reactions.
  • Psychosis or severe mood disturbances.
  • Osteonecrosis of the femoral head.

Precautions & Warnings

Careful assessment and monitoring are required before and during therapy.

  • Infection risk: evaluate for active infections and avoid unnecessary exposure.
  • Glucose monitoring: patients with diabetes need regular blood‑sugar checks.
  • Cardiovascular status: monitor blood pressure and fluid balance.
  • Bone health: consider prophylaxis for osteoporosis in long‑term use.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Methylprednisolone can alter the effects of several concomitant medicines.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid exposure.
  • Live vaccines: risk of uncontrolled infection.
  • NSAIDs: heightened risk of gastrointestinal bleeding.
  • Anticoagulants: enhanced anticoagulant effect.
  • Diuretics: may exacerbate potassium loss.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin): may reduce steroid efficacy.
  • Antidiabetic agents: possible hyperglycaemia, adjust dose as needed.
  • Antihypertensives: steroid‑induced fluid retention may blunt response.
  • Non‑live vaccines: monitor immune response.
  • Other immunosuppressants: cumulative immunosuppression risk.

Frequently Asked Questions

Metilprednizolon Teva is an intravenous glucocorticoid used for acute asthma and COPD flare‑ups, severe allergic reactions such as anaphylaxis, rheumatic and musculoskeletal inflammatory disorders, various autoimmune diseases, adrenal insufficiency replacement, and to prevent inflammation after surgery.

The drug enters cells and binds to glucocorticoid receptors, forming a complex that moves into the nucleus and modifies gene transcription. This down‑regulates pro‑inflammatory cytokines, reduces leukocyte migration, and suppresses immune activation, providing anti‑inflammatory and immunosuppressive effects.

Dosing is individualized and determined by the prescribing clinician based on the specific indication, severity of the condition, patient weight, and clinical response. The product is supplied as an injectable solution for intravenous administration, and the prescriber sets the exact dose and schedule.

Safety data for methylprednisolone sodium succinate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Methylprednisolone sodium succinate offers rapid onset when given intravenously, making it suitable for emergency situations such as severe asthma attacks or anaphylaxis. Compared with oral prednisone, it provides higher plasma concentrations more quickly, but the overall anti‑inflammatory potency is similar when dose‑adjusted.

The injectable solution should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability.

Metilprednizolon Teva is supplied as a sterile injectable solution for intravenous infusion or bolus injection. Administration is performed by a qualified healthcare professional, following aseptic technique and the dosing instructions provided by the prescriber.

Serious risks include severe infections due to immunosuppression, adrenal insufficiency if therapy is stopped abruptly, gastrointestinal bleeding, anaphylaxis, and rare complications such as osteonecrosis or psychosis. Patients should be monitored closely for these events.

The drug is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, and it should be avoided in individuals with systemic fungal infections unless antifungal therapy is initiated. Caution is also advised for patients with uncontrolled infections, severe hypertension, or active peptic ulcer disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone Sodium Succinate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT